Times New Roman; Symbol; Arial; Courier New; Wingdings by wtj20121


									                   Department of Organ Transplantation
                           Beilinson Campus
Head – E. Mor, M.D., Associate Professor of Surgery

A. Yussim, M.D. Head, Director of Research Unit - Senior Lecturer (Assistant Professor)
N. Bar Nathan, M.D. Head, Pediatric Transpl Service – Instructor
R. Rachamimov, M.D.
E. Shaharabani, M.D.
E. Burstein, M.D.
S. Lustig, M.D.
N. Weizer, M.D.
G. Sibak, M.D.


The Transplantation Research and Tissue Typing Units were established in 1982 as
the research component of the Organ Transplant Program at the Beilinson (currently
Rabin Medical Center). The Transplantation Research Unit, headed by A.Yussim,
M.D. and the Tissue Typing Unit, headed by T. Klein, PhD, each operates a
laboratory employing permanent laboratory technicians and assistants. They also
periodically host medical students as well as physicians doing graduate or
postgraduate research. Both laboratories work in a coordinated fashion to contribute
to the research effort. The majority of studies are funded by academic and industrial
research grants.

Research and Teaching Activities

Research Interests:
In general, the research interests of the department is focused on:
  1. in vivo immunobiology of allograft immune response
  2. organ preservation and viability
  3. development of new methods for minimally invasive diagnosis of rejection,
      viral infections or other complications
  4. scientific evaluation of novel immunosuppressive protocols

Research Implementation
Our research has been implemented in clinical practice for differential diagnosis of
rejection and complications, in establishing novel therapeutic protocols and in
monitoring the posttransplantation course and immunosuppressive treatment.
As a result, after neutralizing anti-HLA antibodies, we have been able to successfully
perform for the first time in this country transplantation with living kidney previously
deemed incompatible with its recipient. In addition, we have achieved the reliable
differential diagnosis of rejection in minimally invasive biopsies thereby improving
transplantation success rate by judicious utilization of new immunosuppressive drugs

and strategies. For example, the use of plasmapheresis and intravenous infusion of
IVIG for successful control of humoral rejection, which was previously considered to
be intractable.

The staff of the Research and Tissue Typing Units is also very active in lecturing
students, departmental and hospital staff on topics of transplantation biology, post-
transplant monitoring and immunosuppression.
The following doctoral and post-doctoral candidates have conducted their research
thesis at our Research Unit:

M.D. Thesis
Sara Morgenstern
Morphological findings by light and electron microscopy in kidney transplant
biopsies after treatment with cyclosporine.
Sackler Faculty of Medicine, Tel Aviv University, Israel.

Sosna Yaacov
The impact of Imuran on experimental amyloidosis in mice.
Sackler Faculty of Medicine, Tel Aviv University, Israel.

Sternberg Itai
Peripheral microchimerism in renal transplant recipients
Rappaport Faculty of Medicine, Israel Institute of Technology-Technion, Haifa,

Resident’s Basic Science Project
Gabriela Boxenboim
Parameters of endothelial injury in transplantation.
Kaplan Medical Center, Rehovot, Israel.

Danielle Smith
Experimental xenotransplantation of immune-isolated islets of Langerhans
Fogarty Program, Brown University, USA

PhD Basic Science Project

Archil Chkhotua
SA Beta-Galactosidase – new marker of cell replicative senescence in renal injury
University of Tbilisi, Georgia

List of Publications

Our research has also received national and international recognition, as manifested
by active participation of our researchers in the most prestigious and important
transplant meetings, which resulted in numerous publications (selection):

Z. Ben-Ari, E. Mor, E. Shaharabani, N. Bar-Nathan, Z. Shapira, R. Tur-Kaspa
Conversion of liver allograft recipients from cyclosporine A to FK 506
immunosuppressive therapy.
Transplant Proc, 32(4):709-10, 2000

E. Mor, R. Michowiz, T. Ashkenazi, E. Shabtai, R. Nakache, A. Eid, A. Hoffman,
S. Mizrahi, M. Shabtai, Z. Shapira
Extension of the organ pool in kidney transplantation: first year experience of
the Israel Transplant Center.
Isr Med Assoc J, 2(4):302-5, 2000

A. Korzets, E. Mor, A. Chagnac, Y. Ori, N.B. Nathan, U. Gafter
Procurement of a cadaveric liver transplant from a chronically hemodialyzed
Nephrol Dial Transplant, 15(2):285-6, 2000

T. Klein, Z. Shapira, N. Bar Nathan, E. Shaharabani, H. Or, C. Zakai, E. Shabtai,
A. Yussim
Lack of correlation between HLA match and long-term survival in living donor
kidney transplantation.
Transplant Proc, 32(4):692-3, 2000

A. Yussim, Z. Shapira
Single-bolus high-dose ATG for prophylaxis of rejection in renal
transplantation-a prospective, randomized study.
Transpl Int,13:S293-4, 2000

I.A. Sternberg, T. Klein, R. Narinsky, A. Yussim
Peripheral microchimerism in living donor kidney transplantation-correlation
with posttransplantation course and long-term graft survival.
Transplant Proc, 32(4):690-1, 2000

T. Klein, H. Or, C. Zakai, Z. Shapira, A. Yussim
Successful interspousal swap of ABO incompatible living donor kidneys.
Transplant Proc, 32(4):688-9, 2000

Z. Shapira, A.Yussim
Transplant Proc, 32(4):677, 2000

A. Chkhotua, A. Yussim, A. Tovar, M. Weinberger, V. Sobolev, N. Bar-Nathan,
E. Shaharabani, Z. Shapira, E. Mor
Mucormycosis of the renal allograft: case report and review of the literature.
Transpl Int, 14(6):438-41, 2001

C. Ponticelli, A. Yussim, V. Cambi, C. Legendre, G. Rizzo, M. Salvadori, D. Kahn,
H. Kashi, K. Salmela, L. Fricke, U. Heemann, J. Garcia-Martinez, R. Lechler,
H. Prestele, D. Girault
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple
therapy in kidney transplant recipients.
Transplantation, 15;72(7):1261-7, 2001

E. Mor, L. Helfmann, S. Lustig, N. Bar-Nathan, A. Yussim, B.A. Sela
Homocysteine levels among transplant recipients: effect of immunosuppressive
Transplant Proc, 33(6):2945-6, 2001

E. Mor, E. Shaharabani, Z. Ben-Ari, N. Bar-Nathan, A. Yussim, R. Shapira,
R. Tur-Kaspa, Z. Shapira
Experience with 100 liver transplant recipients at the Rabin Medical Center and
Schneider Children's Medical Center.
Transplant Proc, 33(6):2943-4, 2001

E. Mor, J. Cohen, E. Erez, A. Grozovsky, E. Shaharabani, N. Bar-Nathan, A. Yussim,
R. Micowiz, Z. Shapira, P. Zinger
Short intensive care unit stay reduces septic complications and improves outcome
after liver transplantation.
Transplant Proc, 33(6):2939-40, 2001

A. Chkhotua, Z. Shapira, A. Tovar, E. Shabtai, A. Yussim
Cellular senescence: a new marker of kidney function recovery after ischemic
injury in rats.
Transplant Proc, 33(6):2910-5, 2001

A. Yussim
Transplant Proc, 33(6):2887, 2001

C. Ponticelli, A. Yussim, V. Cambi, C. Legendre, G. Rizzo, M. Salvadori, D. Kahn,
S.H. Kashi, K. Salmela, L. Fricke, J. Garcia-Martinez, R. Lechler, U. Heemann, F.
Monteon, J. Ortuno, J.J. Amenabar, M. Arias, M.L. Nicholson, H. Sperschneider,
D. Abendroth, C. Gracida, M. Lao, M.S. Sever, N. Lameire, A. Sanchez-Fructuoso,
A. Basci, G. Segoloni, J. Connolly, P. Altieri, J. Akoh, H. Prestele, D. Girault
Basiliximab significantly reduces acute rejection in renal transplant patients
given triple therapy with azathioprine.
Transplant Proc, 33(1-2):1009-10, 2001

Z. Shapira, A. Yussim
Organ transplantation in Israel.
Clin Transpl, 367, 2001

E. Mor, O. Pappo, N. Bar-Nathan, E. Shaharabani, Z. Shapira, R. Tur-Kaspa,
Z. Ben-Ari
Defibrotide for the treatment of Venn-occlusive disease after liver
Transplantation, 15;72(7):1237-40, 2001

R. Shapira, R. Zemel, S. Gerecht, E. Mor, Z. Ben-Ari, I. Zahavi, G. Dinari,
R. Tur-Kaspa
Transfusion-transmitted virus in liver-transplanted children.
Transplant Proc, 33(6):2957-8, 2001

E. Mor, T. Klein, E. Shabtai, Z. Ben-Ari, J.W Ortegel, R. Micowitz, R. Tur-Kaspa,
A.R. Tambur
Cytokine gene polymorphism in liver allograft recipients.
Transplant Proc, 33(6):2941-2, 2001

J. Cohen, M. Shapiro, E. Grozovski, E. Mor, E. Shaharabani, Z. Shapira, P. Singer
Should hypoalbuminemia after liver transplantation be corrected?
Transplant Proc, 33(6):2916-7, 2001

Z. Ben-Ari, E. Mor, V. Manhaim, O. Barak, N. Bar-Nathan, E. Shaharabani,
Z. Shapira, R. Tur-Kaspa
Passive immunization with OMRI-Hep-B for prevention of hepatitis B virus
reinfection after liver transplantation.
Transplant Proc, 33(6):2895-6, 2001

R. Shapiro, I. Weismann, H. Mandel, B. Eisenstein, Z. Ben-Ari, N. Bar-Nathan,
I. Zehavi, G. Dinari, E. Mor
Primary hyperoxaluria type 1: improved outcome with timely liver
transplantation: a single-center report of 36 children.
Transplantation, 15;72(3):428-32, 2001

R. Shapira, E. Mor, N. Bar-Nathan, E.M. Sokal, R. Tur-Kaspa, G. Dinari, Z. Ben-Ari
Efficacy of lamivudine for the treatment of hepatitis B virus infection after
liver transplantation in children.
Transplantation, 27;72(2):333-6, 2001

A.R.Tambur, J.W. Ortegel, Z. Ben-Ari, E. Shabtai, T. Klein, R. Michowiz,
R. Tur-Kaspa, E. Mor
Role of cytokine gene polymorphism in hepatitis C recurrence and allograft
rejection among liver transplant recipients.
Transplantation, 27;71(10):1475-80, 2001

E. Mor
Current advances in liver support systems.
Isr Med Assoc J, 3(1):41-3, 2001

Z. Ben-Ari, E. Mor, Z. Shapira, R. Tur-Kaspa
Long-term experience with lamivudine therapy for hepatitis B virus infection
after liver transplantation.
Liver Transpl, 7(2):113-7, 2001

Z. Ben-Ari, E. Mor, E. Shaharabani, N. Bar-Nathan, Z. Shapira, R. Tur-Kaspa
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C
virus infection after liver transplantation.
Transplant Proc, 32(4):714-6, 2001

E. Atar, A. Belenky, M. Neuman-Levin, A. Yussim, N. Bar-Nathan, G.N. Bachar
Nonfunctioning Renal Allograft Embolization as an Alternative to Graft
Nephrectomy: Report on Seven Years' Experience.
Cardiovasc Intervent Radiol, 20, 2002

A. Chkhotua, M. Shohat, A. Tobar, N. Magal, E. Kaganovski, Z. Shapira, A. Yussim
Replicative senescence in organ transplantation-mechanisms and significance.
Transpl Immunol, 9(2-4):165-71, 2002

E. Mor, N. Bar-Nathan, R. Shapira, M. Katchko, G. Dinari
Porto-systemic shunts in children: Schneider Children's Medical Center
Harefuah, 141(11):953-6, 1011, 2002

A. Tambur, P. Heeger, T. Klein, Z. Ben-Ari, N. Herrera, E. Mor
Frequency of donor-specific IFN-gamma-producing lymphocytes correlates with
post-transplant course of liver transplant recipients.
Hum Immunol, 63(10 Suppl):S72, 2002

E. Mor
Living-related segmental liver transplantation: broadening application in adult
Harefuah, 141(7):603-5, 666, 2002

R. Shapira, N. Daudi, A. Klein, D. Shouval, E. Mor, R. Tur-Kaspa, G. Dinari,
Z. Ben-Ari
Seroconversion after the addition of famciclovir therapy in a child with
hepatitis B virus infection after liver transplantation who developed lamivudine
Transplantation, 15;73(5):820-2, 2002


To top